Alphatec Holdings

Valuation Analysis

About the Company

Alphatec Holdings en bref

Alphatec Holdings (ATEC) is currently trading at 7,69 € with a market capitalization of 1,2 Md €. The 52-week range spans from 5,95 € to 20,32 €; the current price is 62.2% below the yearly high. Year-over-year revenue growth stands at +13.6%.

💰 Dividende

Alphatec Holdings currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

11 analystes évaluent Alphatec Holdings (ATEC) au consensus : None. L'objectif de cours moyen est de 14,60 €, soit un potentiel de +89.87% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 9,60 € à 20,94 €.

Alphatec Holdings : la thèse d'investissement en détail

Alphatec Holdings (ATEC) operates in the Healthcare — specifically Medical Devices — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Revenue is growing at a healthy 13.6% pace year-over-year, suggesting the business model continues to find new customers and pricing power. With a gross margin near 70.18%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns.

Le scénario baissier

Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders. The debt-to-equity ratio of 3303.35% is elevated, meaning the company relies heavily on creditors — refinancing terms will become more important than operational performance in the next economic downturn.

Valorisation en contexte

With a PEG ratio of 0.48, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity. The EV/EBITDA multiple of 62.83x reflects rich expectations — historically, multiples at this level have proven hard to maintain for more than a few quarters.

À surveiller

• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 89.87% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

The data points to relatively defensive market behavior, elevated short interest (9.01%), higher leverage relative to equity.

Trading Data

Related Stocks in the Same Sector

Where can I buy Alphatec Holdings?

Compare top-rated brokers — low fees, trusted providers, fully regulated.